TIX100, a TXNIP inhibitor, has received FDA Investigational New Drug approval and demonstrated safety in early trials
Klinic handles the paperwork, follows up with your insurer, and assists with appeals if needed
Side effects are generally mild and decrease over time
Phosphatidylcholine (PC) used in mesotherapy is soy in origin and egg yolks, pregnancy or breast feeding, immuno-compromised, liver and renal failure, microangiopathy, peripheral artery disease, and vascular insufficiency, autoimmune except Hashimotos and rheumatoid arthritis, anticoagulant agents, hemophiliacs, active infection in the treated area and history of scarring/pigmentation after injections
Ipamorelin is a growth hormone-releasing peptide (GHRP) that triggers the release of the growth hormone in the pituitary gland
All storage and handling must follow the sponsor's Investigational Medicinal Product Dossier (IMPD) or Investigator's Brochure, which will contain formulation-specific stability data